TFA Therapeutics (RAJAF) EBT Margin (2020 - 2023)
TFA Therapeutics (RAJAF) posted EBT Margin of 26.44% for Q4 2023, up 106.81% on a QoQ basis from 388.37% in Q4 2022, and up 41481.0% year-over-year from N/an in Q4 2022.
Powered by 
Analysis
TFA Therapeutics (RAJAF) EBT Margin (2020 - 2023) Analysis & Trends
TFA Therapeutics has reported EBT Margin for 3 years, with the latest figure at 26.44% in Q4 2023.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Colgate Palmolive | 70.54 Bn | 69.17 Bn | 3.30 Bn | 17.72% |
| 2 | Kenvue | 34.15 Bn | 33.04 Bn | 2.30 Bn | 15.12% |
| 3 | Kimberly Clark | 32.75 Bn | 31.80 Bn | 1.60 Bn | 13.65% |
| 4 | Bath & Body Works | 3.74 Bn | 2.95 Bn | 692.00 Mn | 10.83% |
| 5 | Prestige Consumer Healthcare | 2.28 Bn | 2.22 Bn | - | - |
| 6 | Perrigo | 1.91 Bn | 1.52 Bn | 313.90 Mn | 10.31% |
| 7 | Herbalife | 1.28 Bn | 911.72 Mn | 1.03 Bn | -0.28% |
| 8 | Edgewell Personal Care | 1.22 Bn | 825.47 Mn | 242.50 Mn | 3.16% |
| 9 | TFA Therapeutics | 1.02 Bn | 1.02 Bn | - | - |
| 10 | Honest Company | 596.31 Mn | 490.41 Mn | 40.36 Mn | 12.91% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2023 | 26.44% |
| Dec 31, 2022 | -388.37% |
| Dec 31, 2020 | -8.56% |